[221]
This argument was rejected in the
Novopharm
Trial, and has also been rejected by the Court of Appeal in
Pfizer v. Ratiopharm
. (
Novopharm
, above at para. 106;
Pfizer v. Ratiopharm
, above at paras. 35-36, reving. 288 F.T.R. 215; 2006 FC 220.)
Sufficiency of Disclosure